Retinal migraine: causes, symptoms, diagnosis, and management

Features and clinical presentation

Typical features include sudden onset of visual symptoms in a single eye: a dark patch, flashing lights, shimmering scotoma, or transient blindness. These signs are often brief and reversible. A headache resembling migraine may follow, occur during, or be absent. Other associated features can include nausea, photophobia, or sensitivity to movement. Because the visual loss is monocular, retinal migraine should be distinguished from the more common migraine with visual aura (cortical aura), which usually produces binocular visual phenomena that affect the same part of the visual field in both eyes.

Underlying mechanisms and risk factors

The pathophysiology is not fully settled. Many clinicians believe episodes arise from transient vasospasm of retinal arterioles or other transient retinal ischemia. Vasospasm means the muscular walls of small blood vessels constrict temporarily, reducing blood flow. Other contributors under investigation include vascular dysregulation and hyperexcitability of neural pathways serving the retina. Typical triggers mirror those of other migraines: stress, bright light, hormonal changes, dehydration, certain medications, or tobacco. Relative predominance in women and onset in younger adults is reported in clinical series.

Diagnosis and differential considerations

Diagnosis relies on a careful history and examination and on excluding alternative causes of monocular visual loss. Important conditions to consider include:

• Transient ischemic attack (TIA) or amaurosis fugax from embolic disease
• Retinal artery occlusion or other retinal vascular disorders
• Optic neuropathies and inflammatory eye disease
• Cortical visual aura (usually binocular and migratory across the visual field)

An ophthalmologic exam, visual field testing, optical coherence tomography (OCT), fluorescein angiography, and sometimes neuroimaging or vascular studies are used to rule out structural or vascular causes. Because some retinal events may herald systemic vascular disease, evaluation of cardiovascular risk factors is often recommended. When in doubt, referral to an eye specialist or neurologist is appropriate.

Management and prognosis

Most retinal migraine attacks resolve without permanent damage, but repeated or prolonged ischemia can threaten vision, so prompt assessment is important. Acute measures are supportive: resting in a darkened room and addressing pain or nausea. Preventive steps focus on identifying and modifying triggers, controlling vascular risk factors (blood pressure, smoking cessation), and treating coexisting migraine disorders when present. Some clinicians avoid strongly vasoconstrictive migraine drugs (for example, ergotamines or triptans) if retinal vasospasm is suspected, and will consider alternative preventive medications or vascular-directed therapies on a case-by-case basis. Decisions about medication should be individualized and made with a specialist when necessary.

Distinguishing facts and further information

Because terminology varies, patients and clinicians should use precise descriptions: "monocular transient visual loss" or "retinal migraine" for one-eye events, and "migraine with visual aura" for binocular cortical phenomena. If you experience sudden monocular vision loss, especially for the first time or with vascular risk factors, seek urgent evaluation to exclude an embolic or ischemic event. For general information on headaches and migraine classifications see relevant clinical guidance.

Note: This article summarizes commonly accepted aspects of retinal migraine. It does not replace individualized medical advice; evaluation by an eye care professional or neurologist is recommended for diagnosis and treatment planning.